Feasibility of single-site laparoscopic colectomy with complete mesocolic excision for colon cancer: a prospective case–control comparison
Open Access
- 8 November 2013
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 28 (4) , 1110-1118
Abstract
Background Single-site laparoscopic colectomy (SLC) is an emerging concept that, compared with conventional multiport laparoscopic colectomy (MLC), yields reduced postoperative pain and improved cosmesis. Complete mesocolic excision (CME) is a novel concept for colon cancer surgery that provides improved oncologic outcomes; however, there are no reports of SLC with CME. We conducted a prospective case–control study to evaluate the feasibility and safety of SLC with CME for colon cancer. Methods Prospectively collected data of patients with stage I-III colon cancer who underwent SLC (n = 150) or MLC (n = 150) between June 2008 and March 2012 were analyzed. Patients who underwent SLC were, in terms of clinical characteristics and tumor location, matched as closely as possible with those undergoing MLC. Within each group, patients were classified as having right-sided (n = 69 in each group) or left-sided (n = 81 in each group) colon cancer, and short-term outcomes were compared between the two procedures overall and per side. Results Overall perioperative outcomes, including operation time, blood loss, number of lymph nodes harvested, length of the resected specimen, and complications, were similar between the two procedures, whereas postoperative pain was significantly lower with SLC. Operation time for right-sided SLC was significantly shortened. SLC with CME was completed successfully in 94 % (65/69) of right-sided cases and in 88 % (71/81) of left-sided cases. Conversion rates were 1.4 % (1/69) and 1.1 % (1/81), respectively. The umbilical scars were nearly invisible 3 months after the procedure, and most patients reported being quite satisfied with the cosmetic outcomes. Conclusions SLC with CME for colon cancer is feasible when performed by experienced surgeons in selected patients. Excellent cosmesis and reduced postoperative pain as well as oncologic clearance can be expected. A large-scale, prospective, randomized, controlled trial should be conducted to confirm the superiority of this procedure over MLC with CME.Keywords
This publication has 28 references indexed in Scilit:
- Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategiesSurgical Endoscopy, 2012
- Laparoscopic complete mesocolic excision for right colon cancerSurgical Endoscopy, 2012
- Single-incision versus conventional laparoscopic colectomy for colonic neoplasm: a randomized, controlled trialSurgical Endoscopy, 2012
- Feasibility and Safety of Single-Incision Laparoscopic ColectomyAnnals of Surgery, 2012
- Comparison of clinical outcome of single‐incision laparoscopic surgery using a simplified access system with conventional laparoscopic surgery for malignant colorectal diseaseColorectal Disease, 2012
- The Short-term Outcomes of Conventional and Single-port Laparoscopic Surgery for Colorectal CancerAnnals of Surgery, 2011
- Single-incision versus conventional laparoscopic sigmoid colectomy: a case-matched seriesSurgical Endoscopy, 2011
- Can the quality of colonic surgery be improved by standardization of surgical technique with complete mesocolic excision?Colorectal Disease, 2010
- Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trialThe Lancet, 2005
- Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trialThe Lancet, 2004